149
Views
6
CrossRef citations to date
0
Altmetric
Original Articles

Nucleoside transporters are critical to the uptake and antioxidant activity of 7,8-dihydroneopterin in monocytic cells

, ORCID Icon &
Pages 341-350 | Received 18 Dec 2019, Accepted 29 Apr 2020, Published online: 18 May 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Nooshin Ghodsian, Anthony Yeandle, Barry D. Hock & Steven P. Gieseg. (2022) CD36 down regulation by the macrophage antioxidant 7,8-dihydroneopterin through modulation of PPAR-γ activity. Free Radical Research 56:5-6, pages 366-377.
Read now

Articles from other publishers (5)

Ondrej Heneberk, Eliska Wurfelova & Vladimira Radochova. (2023) Neopterin, the Cell-Mediated Immune Response Biomarker, in Inflammatory Periodontal Diseases: A Narrative Review of a More than Fifty Years Old Biomarker. Biomedicines 11:5, pages 1294.
Crossref
Yang Guo, Lingfeng Meng, Minxiao Wang, Zhaoshan Zhong, Denghui Li, Yaolei Zhang, Hanbo Li, Huan Zhang, Inge Seim, Yuli Li, Aijun Jiang, Qianyue Ji, Xiaoshan Su, Jianwei Chen, Guangyi Fan, Chaolun Li & Shanshan Liu. (2023) Hologenome analysis reveals independent evolution to chemosymbiosis by deep-sea bivalves. BMC Biology 21:1.
Crossref
Weiyong Hong, Bang Lou, Ying Gao, Hui Zhao, Sanjun Ying, Saicheng Yang, Hanbing Li, Qingliang Yang & Gensheng Yang. (2023) Tumor microenvironment responded naturally extracted FOF1-ATPase loaded chromatophores for antitumor therapy. International Journal of Biological Macromolecules 230, pages 123127.
Crossref
Jun Wang, Wen-Yu Yang, Xiao-Han Li, Bei Xu, Yu-Wei Yang, Bin Zhang, Chun-Mei Dai & Jia-Fu Feng. (2022) Study on potential markers for diagnosis of renal cell carcinoma by serum untargeted metabolomics based on UPLC-MS/MS. Frontiers in Physiology 13.
Crossref
Takuya Watanabe. (2021) Neopterin derivatives – a novel therapeutic target rather than biomarker for atherosclerosis and related diseases. Vasa 50:3, pages 165-173.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.